Europe Secures 100 Million More Doses of BioNTech/Pfizer Vaccine

GALWAY, IRELAND--April 28, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Union (EU) has agreed to purchase an extra 100 million doses of the BioNTech/Pfizer COVID-19 vaccine in an effort to overcome severe supply issues in the region caused by the temporary halt on supplies of vaccines from AstraZeneca (Cambridge, U.K.) and Johnson & Johnson (NYSE:JNJ) (New Brunswick, New Jersey) over health concerns.

Within this article: Details new EU COVID-19 vaccines order, existing supply problems, potential new suppliers, growing production network